Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Common Equity (2022 - 2025)

SBC Medical Group Holdings filings provide 4 years of Common Equity readings, the most recent being $248.3 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 27.31% to $248.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $248.3 million, a 27.31% increase, with the full-year FY2025 number at $248.3 million, up 27.31% from a year prior.
  • Common Equity hit $248.3 million in Q4 2025 for SBC Medical Group Holdings, roughly flat from $248.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $248.3 million in Q4 2025 to a low of $103.3 million in Q1 2023.
  • Median Common Equity over the past 4 years was $160.7 million (2024), compared with a mean of $174.1 million.
  • Biggest five-year swings in Common Equity: skyrocketed 67.62% in 2024 and later increased 20.66% in 2025.
  • SBC Medical Group Holdings' Common Equity stood at $107.9 million in 2022, then skyrocketed by 33.34% to $143.8 million in 2023, then soared by 35.61% to $195.0 million in 2024, then increased by 27.31% to $248.3 million in 2025.
  • The last three reported values for Common Equity were $248.3 million (Q4 2025), $248.0 million (Q3 2025), and $244.7 million (Q2 2025) per Business Quant data.